ConductScience.org, home

Trial · NCT06040840

WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release

NCT06040840, Not applicable, Completed, CMC Ambroise Paré

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release. Trials, record NCT06040840. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06040840

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release
NCT number
NCT06040840
Status
Completed
Phases
Not applicable
Enrollment
130 participants, actual
Lead sponsor
CMC Ambroise Paré
Conditions
Carpal Tunnel Syndrome
Interventions
BAX, Tourniquet, Lidocaine, WALANT, Lidocaine + Epinephrine
First posted
2023-09-18
Last updated
2026-04-08

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryRegional anesthesia success2 hoursNeed (or not) for additional anesthetic procedure during surgery: analgesics, sedation, general anesthesia, local anesthetics
SecondarySurgery duration2 hoursTime (in minutes) between the skin incision and the wound dressing procedure.
SecondaryLength of hospital stay24 hoursTime (in minutes) between ward admission and discharge.
SecondaryDischarge criteria assessed by PADSS24 hoursTime (in minutes) between the regional anesthesia and the ability to discharge defined by the modified Post Anesthesia Discharge Scoring System (PADSS) who achieve a score of 9 or more.
SecondaryPatient satisfaction assessed by EVAN-LR self-reported questionnaire24 hours
EVAN-LR self-reported questionnaire comprising 19 items structured in five dimensions, depending on their content: Attention (4 items), Information (5 items), Discomfort (4 items), Waiting (2 items), and Pain (4 items). Each item is linearly transformed to a 0-100 scale, with 100 indicating the best possible level of satisfaction and 0 the worst.
SecondaryPostoperative pain at the surgical site assessed by VRS24 hoursMaximum postoperative pain at the surgical site will be assessed at Day-0 et at Day-1 using a Verbal Rating Scale (VRS) ranging from 0 to 10 (0=no pain, 10=worst possible pain).
SecondarySurgical site bleeding2 hoursSurgeon's clear-field satisfactory score: 1=bloodless, 2=little blood, 3=bloody field but performable, 4=bloody field
SecondaryRate of complications24 hoursIncidence of complications related to RA procedure: vascular puncture, paresthesia, local anesthetic systemic toxicity

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
41233154RESULT

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06040840

GET https://conductscience.org/api/trials/v1/NCT06040840/registered